The invention relates to an Rh group incompatibility therapeutic apparatus in the field of
medical science. The Rh group incompatibility therapeutic apparatus is characterized in that rhesus monkey red blood cells containing human common Rh
antigen are alternately washed by PB lysate with the
osmotic concentration of 25 and 35mmol / L, ghost cells dialyzed with
hemoglobin, retaining Rh
antigenicity and capable of adsorbing an Rh
antibody are prepared and fixed to
agarose with special concentration together with the Rh
antibody prepared by
immunology according to a specific ratio, the
agarose is placed into a cylindrical adsorber made of high-
biocompatibility materials,
antibody valence from high to low and
agarose concentration from low to high are formed from a sample inlet end to a sample outlet end, the ghost cells are uniformly distributed,
red blood cell destruction products of patients suffering from group incompatibility can be effectively intercepted by the agarose with gradually increased special concentration and gradually decreased molecular micropores at the sample inlet end and the sample outlet end and a mesh screen at an outlet of the adsorber, and a novel therapeutic method for
maternal fetal Rh group incompatibility does not remove
plasma components and avoids toxic and side effects.